tolbutamide has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, I; Miyazaki, J; Ogata, E; Sekine, N; Yamashita, N | 1 |
| Mayer, SI; Thiel, G | 1 |
2 other study(ies) available for tolbutamide and transforming growth factor beta
| Article | Year |
|---|---|
Bimodal effect of transforming growth factor-beta on insulin secretion in MIN6 cells.
Topics: Animals; Colforsin; Dose-Response Relationship, Drug; Glucose; Humans; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Mice; Pancreatic Neoplasms; Tolbutamide; Transforming Growth Factor beta; Tumor Cells, Cultured | 1994 |
Calcium influx into MIN6 insulinoma cells induces expression of Egr-1 involving extracellular signal-regulated protein kinase and the transcription factors Elk-1 and CREB.
Topics: Animals; Calcium; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Dual Specificity Phosphatase 1; Early Growth Response Protein 1; Enzyme Activation; Epigenesis, Genetic; ErbB Receptors; ets-Domain Protein Elk-1; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Glucose; Hypoglycemic Agents; Insulinoma; Mice; Potassium Chloride; Protein Kinase C; PTEN Phosphohydrolase; Signal Transduction; Ternary Complex Factors; Tolbutamide; Transcriptional Activation; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |